Compugen (CGEN) Treasury Shares (2024 - 2025)
Compugen (CGEN) posted quarterly Treasury Shares of $567400.0 for Q4 2025, up 78.79% year-over-year from $317350.0 in Q4 2024, and up 74.18% on a QoQ basis from $325750.0 in Q2 2025.
Compugen (CGEN) Treasury Shares (2024 - 2025) Analysis & Trends
Compugen has reported Treasury Shares for 2 years, with the latest figure at $567400.0 in Q4 2025.
- Treasury Shares for Q4 2025 came in at $567400.0, up 78.79% year-over-year; the trailing twelve-month figure through Dec 2025 was $567400.0 (up 78.79% YoY), and the FY2025 annual result was $567400.0, up 78.79% from the prior year.
- Treasury Shares advanced to $567400.0 in Q4 2025, from $325750.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $567400.0 in Q4 2025 and troughed at $317350.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Compugen | 227.88 Mn | 136.13 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 567,400.00 |
| Dec 31, 2025 | 567,400.00 |
| Jun 30, 2025 | 325,750.00 |
| Jun 30, 2025 | 325,750.00 |
| Dec 31, 2024 | 317,350.00 |
| Dec 31, 2024 | 317,350.00 |